Jeremy Grantham's position in Bio-Rad Laboratories is currently worth $27.3 Million. That's 0.12% of their equity portfolio (133rd largest holding). The first Bio-Rad Laboratories trade was made in Q4 2017. Since then Jeremy Grantham bought shares eleven more times and sold shares on four occasions. The investor's estimated purchase price is $50 Million, resulting in a loss of 45%.